FDA NDC Directory · JSON-LD · Markdown

Levothyroxine Sodium

NDC 51655-696 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerNorthwind Health Company, LLC
Marketing categoryNew Drug Application (innovator) · App NDA021210
Dosage form / routeTABLET · ORAL
Active ingredientsLEVOTHYROXINE SODIUM (.125 mg/1)
Marketing started20210401
Package count1

External sources

Source: openFDA. Public-domain (CC0).